The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma

Primary mediastinal large B-cell lymphoma (PMBCL) is a subtype of diffuse large B-cell lymphoma (DLBCL). PMBCL comprises approximately 10% of DLBCLs, thus making it a rare variant of DLBCL. Cure rates for PMBCL with upfront regimens like DA-REPOCH exceed 90%. However, if there is a poor response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomassetti, Sarah, Chen, Robert, Dandapani, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477766/
https://www.ncbi.nlm.nih.gov/pubmed/31040936
http://dx.doi.org/10.1177/2040620719841591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477766/
https://www.ncbi.nlm.nih.gov/pubmed/31040936
http://dx.doi.org/10.1177/2040620719841591

Ejemplares similares